Integral Health Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Integral Health Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-325,000	Closed	-$10.9M	–	112
2026 Q1	$10.9M	Hold	325,000	–	–	0.52%	52
2025 Q4	$15M	Buy	+325,000	New	+$17.8M	0.75%	48

Integral Health Asset Management's SLNO Position: Q2 2026 in Review

Integral Health Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 325,000 shares — an estimated $10.9M sold.

Integral Health Asset Management first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $15M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Integral Health Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Integral Health Asset Management sold 325,000 Soleno Therapeutics shares in Q2 2026, an estimated $10.9M.
Integral Health Asset Management first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Integral Health Asset Management's Soleno Therapeutics position peaked at $15M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.